What is the enterprise value (EV) for Silo Pharma, Inc. (SILO)?

The enterprise value (EV) for SILO stock is $-3.10M.

Silo Pharma (SILO) Enterprise Value: History & Chart

Compare

Silo Pharma, Inc.(SILO)

Biotechnology · Sarasota, FL

$1.46-0.03 (-2.01%)

Delayed quote: Oct 6, 2026, 3:49 PM EDT

Compare

About Silo Pharma, Inc.

Silo Pharma Inc. operates as a developmental-stage biopharmaceutical firm dedicated to creating treatments for a variety of underserviced medical conditions. These include stress-related psychiatric disorders, persistent pain syndromes, and diseases impacting the central nervous system (CNS). The company's approach combines both traditional and psychedelic therapies, with a strong emphasis on innovative formulations and advanced drug delivery systems. Leading its pipeline is SPC-15, an intranasal treatment engineered to address post-traumatic stress disorder (PTSD) and anxiety disorders stemming from stress. Another key development is SP-26, a time-release, ketamine-loaded implant designed to provide relief for fibromyalgia and chronic pain. Furthermore, Silo Pharma is advancing two preclinical programs: SPC-14, an intranasal compound targeting Alzheimer's disease, and SPU-16, a CNS-homing peptide intended for the management of multiple sclerosis (MS). The company's research and development efforts frequently involve collaborations with prominent academic institutions such as Columbia University and the University of Maryland, Baltimore. Founded in 2010, the company adopted its current name, Silo Pharma, Inc., in September 2020, having previously operated as Uppercut Brands, Inc. Silo Pharma is headquartered in Sarasota, Florida.

Sarasota, FL

3 employees

silopharma.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Eric Weisblum

View full financials

NAME	MARKET CAP	ENTERPRISE VALUE (EV)
Silo Pharma, Inc. (SILO)	$1.65M	$-3.10M
Lakewood-Amedex Biotherapeutics, Inc. (LABT)vs ›	$1.51M	N/A
Alaunos Therapeutics, Inc. (TCRT)vs ›	$1.80M	$1.68M
PMGC Holdings Inc. (ELAB)vs ›	$1.49M	N/A
NEXGEL, Inc. (NXGL)vs ›	$1.45M	$8.42M
Curis, Inc. (CRIS)vs ›	$1.44M	N/A
Profusa, Inc. Common Stock (PFSA)vs ›	$1.86M	$15.14M
TransCode Therapeutics, Inc. (RNAZ)vs ›	$1.86M	N/A
INVO Fertility, Inc. (IVF)vs ›	$1.42M	$1.61M
Beyond Air, Inc. (XAIR)vs ›	$1.88M	N/A

NAME

MARKET CAP

ENTERPRISE VALUE (EV)

Silo Pharma, Inc. (SILO)

$1.65M

$-3.10M

Lakewood-Amedex Biotherapeutics, Inc. (LABT)vs ›

$1.51M

N/A

Alaunos Therapeutics, Inc. (TCRT)vs ›

$1.80M

$1.68M